Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

Signs of immune system aging appear years before rheumatoid arthritis takes hold, offering new hope for early diagnosis and ...

Stevens-Johnson syndrome (SJS) is a rare, severe and potentially fatal allergic reaction that can cause widespread rash, ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

Diagnosing arthritis has always been a challenge, especially when the two most common types—osteoarthritis and rheumatoid arthritis—can look alike. Both diseases lead to joint pain, stiffness, and ...

The first-ever neuroimmune modulation implant has been approved for people with moderate to severe rheumatoid arthritis (RA) who haven't found relief with traditional medications. It's a potentially ...

Arthritis isn’t a disease that only affects older people. “Arthritis is damage or inflammation to joints, where the bone connects to another bone,” says rheumatologist Donald E. Thomas, Jr., M.D., ...

An innovative new device calms inflammation by delivering a low-voltage jolt of electricity to the vagus nerve. The FDA has approved the SetPoint System, a device implanted in the neck for relieving ...

Patients with rheumatoid and psoriatic arthritis maintained stable disease activity and functional capacity, with even some improvement in ultrasound findings, after switching from original adalimumab ...

Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...

Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...